In this study, we adopted the widely accepted definition in which CK5/6- and/or EGFR-positive breast cancers are classified as BLBC while CK5/6- and EGFR-negative breast cancers are defined as non-basal-like breast cancer (NBLBC). The gene discussed is KRT5; the disease is breast carcinoma.